Taiko Pharmaceutical Co. Ltd. announced consolidated earnings results for the year ended December 31, 2020. For the year, the company reported net sales of JPY 17,582 million. Operating profit was JPY 5,650 million. Profit attributable to owners of parent was JPY 3,851million. Basic earnings per share were JPY 89.18. Diluted earnings per share were JPY 88.82.